Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Visual Prognosis in Non-Penetrating Corneal Blast Injuries

This study has been completed.
Sponsor:
Information provided by:
Walter Reed Army Medical Center
ClinicalTrials.gov Identifier:
NCT00414219
First received: December 20, 2006
Last updated: December 29, 2010
Last verified: December 2010
  Purpose

The purpose of this study is to assess visual quality of patients with non-penetrating, non-metallic, stable corneal foreign bodies. Visual quality will be assessed by examining visual acuity, wavefront analysis and contrast sensitivity. Drawings, photographs, and confocal microscopy will be used to document clinical examination of the cornea at baseline and on follow-up examinations.


Condition Intervention
Corneal Foreign Body Following Blast Injury
Behavioral: Visual quality of patients with corneal eye injuries

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Visual Prognosis in Non-Penetrating Corneal Blast Injuries

Resource links provided by NLM:


Further study details as provided by Walter Reed Army Medical Center:

Estimated Enrollment: 40
Study Start Date: November 2004
Study Completion Date: May 2007
Intervention Details:
    Behavioral: Visual quality of patients with corneal eye injuries
    Visual quality of patients with corneal eye injuries
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

US Army patients age 18 years and older prsenting with corneal foreign bodies from non-penetrating ocular blast injuries

Criteria

Inclusion Criteria:

  • Informed consent
  • Access to medical care at Walter Reed Army Medical Center
  • Age 18 years or older
  • Corneal foreign bodies from blast injuries
  • Available for evaluation at Walter Reed

Exclusion Criteria:

  • Residual, recurrent or active ocular disease in the designated eye as determined by exam and history.
  • Penetrating ocular trauma or injury to the posterior segment
  • Prior history of ocular surgery
  • Any physical or mental impairment that would preclude participation in any of the examinations.
  • Any ocular abnormality other than corneal foreign bodies that have any impact on vision (i.e. other abnormalities from trauma such as retinal detachment, corneal laceration, traumatic cataract, or abnormalities unrelated to trauma such as herpes.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00414219

Locations
United States, District of Columbia
Walter Reed Army Medical Center
Washington, District of Columbia, United States, 20307
Sponsors and Collaborators
Walter Reed Army Medical Center
Investigators
Principal Investigator: Dain Brooks, MD Ophthalmology Service, Walter Reed Army Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00414219     History of Changes
Other Study ID Numbers: WRAMC WU# 04-23010
Study First Received: December 20, 2006
Last Updated: December 29, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Blast Injuries
Eye Foreign Bodies
Foreign Bodies
Barotrauma
Craniocerebral Trauma
Eye Injuries
Facial Injuries
Wounds and Injuries

ClinicalTrials.gov processed this record on November 25, 2014